.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Accenture
Cipla
Julphar
Cantor Fitzgerald
Federal Trade Commission
UBS
Healthtrust
Cerilliant

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020652

« Back to Dashboard

NDA 020652 describes TESLASCAN, which is a drug marketed by Ge Healthcare and is included in one NDA. Additional details are available on the TESLASCAN profile page.

The generic ingredient in TESLASCAN is mangafodipir trisodium. Additional details are available on the mangafodipir trisodium profile page.

Summary for 020652

Tradename:1
Applicant:1
Ingredient:1
Patents:0

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength37.9MG/ML
Approval Date:Nov 26, 1997TE:RLD:No

Expired Orange Book Patents for NDA: 020652

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
AstraZeneca
Chinese Patent Office
Dow
Citi
Harvard Business School
Baxter
Accenture
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot